相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C Pharmacogenetics: State of the Art in 2010
Nezam H. Afdhal et al.
HEPATOLOGY (2011)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C
Hironobu Tsukada et al.
GASTROENTEROLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The GNB3 C825T polymorphism affects response to HCV therapy with pegy1ated interferon in HCV/HIV co-infected but not in HCV mono-infected patients
Golo Ahlenstiel et al.
JOURNAL OF HEPATOLOGY (2007)
Treatment of chronic hepatitis C virus in african americans with genotypes 2 and 3
Mitchell L. Shiffman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin
Jian-Wu Yu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Signaling networks from Gβ1 subunit to transcription factors and actin remodeling via a membrane-located ERβ-related protein in the rapid action of daidzein in osteoblasts
Anne De Wilde et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S. Conjeevaram et al.
GASTROENTEROLOGY (2006)
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection
C Sarrazin et al.
JOURNAL OF HEPATOLOGY (2005)
SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
M Naito et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Host factors and failure of interferon-α treatment in hepatitis C virus
B Gao et al.
HEPATOLOGY (2004)
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C
HE Wasmuth et al.
HEPATOLOGY (2004)
Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection
T Mueller et al.
JOURNAL OF HEPATOLOGY (2004)
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection
S Knapp et al.
IMMUNOGENETICS (2003)
Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection
LJ Yee et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon
N Matsuyama et al.
HEPATOLOGY RESEARCH (2003)
Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1
T Mueller et al.
HEPATOLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C
Y Sugimoto et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon
M Hijikata et al.
INTERVIROLOGY (2000)
分享论文
